|
|
|
 |
 |
|
|
| |
Type 1 Diabetes Cure,
DiabeCell®? Early trial results are promising. - - - October 22, 2007 Sydney Morning Herald http://tinyurl.com/24y7fk - - - Excerpts: ... [Cell therapy company Living Cell Technologies Ltd] medical director Professor Bob Elliott said early stage results of the product, DiabeCell, "have ex- ceeded our expectations". Prof Elliott said the first patient was injected with his first dose of DiabeCell in June without adverse ef- fects, resulting in the patient's insulin requirement being reduced. "Control of blood glucose levels has been maintained while his daily insulin requirement was gradually reduced by about 40 per cent over the past four months," Prof Elliott said. Prof Elliott said the second recipient was implanted with her first dose of DiabeCell last month without adverse effects. "At one month following the implant, the patient has been weaned off insulin altogether," he said. ... Living Cell is trialling DiabeCell on six patients at the Sklifosovsky Institute in Moscow, Russia. Patients each receive two transplants of small doses of live micro-encapsulated pig islets that are injected into their abdominal. - - - end excerpts - - - - - - Breakthrough In Diabetes Treatment http://tinyurl.com/qwrlm4 - - - Excerpts: ... DiabeCell® is a treatment for insulin-dependent dia- betes which is administered to patients without the need for immunosuppressant drugs. The trial in Russia will determine whether a small dose of live microencapsulated pig islets injected into the abdominal cavity of type I diabetic patients is safe and can produce enough insulin to have a measurable effect on improving the control of blood glucose levels. Medical Director of Living Cell, Professor Bob Elliott, said two patients have been implanted with their first dose of DiabeCell® and are due for a second dose in 6 months. ... Six more patients will be receiving two transplants of the smallest dose of DiabeCell® which is equiva- lent to one third of the maximum dose. A trial of maximum dose transplants is planned for testing in a proposed New Zealand study. ... - - - end excerpts - - -
|
|
|
| |
|
|
 |
